Dendritic cells as central coordinators of oncolytic virus-induced antitumor immunity. Ehab M Ezzaldeen
Semin Immunol. 2026 May 18;82:102033. doi: 10.1016/j.smim.2026.102033. Online ahead of print. ABSTRACT Antigen-presenting cells shape the efficacy of cancer immunotherapies by providing essential signals required for antitumor T-cell response. Dendritic cells (DCs) are central to oncolytic virus (OV)-induced antitumor immunity because they couple tumor-antigen acquisition to cross-presentation and T-cell priming in tumor-draining lymph nodes. In … Read more